Company shifts from paid media as Q2 2026 revenue hits $47.3 million with a $3.5 million adjusted EBITDA loss.
LifeMD projected Q4 2026 revenue between $60 million and $64 million, alongside adjusted EBITDA guidance of $3 million to $6 million. The outlook reflects a strategic pivot away from paid media channels to reduce customer acquisition costs.
In Q2 2026, the company reported $47.3 million in revenue, aligning with prior guidance. Adjusted EBITDA swung to a $3.5 million loss, driven by higher early-quarter acquisition costs and operational adjustments. Management cited progress in refining marketing efficiency despite near-term pressure.